Stock Ratings from Analyst Ratings Network

Open Main Menu Open Sidebar

Can Fite Biopharma Ltd (ADR) Company Profile (NASDAQ:CANF)

Consensus Ratings for Can Fite Biopharma Ltd (ADR) (NASDAQ:CANF) (?)
Ratings Breakdown: 2 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $14.00 (310.56% upside)

Analysts' Ratings History for Can Fite Biopharma Ltd (ADR) (NASDAQ:CANF)
Show:
DateFirmActionRatingPrice TargetDetailsShare
11/18/2014HC WainrightInitiated CoverageBuy$7.00ViewTweet This Rating  Share This Rating on StockTwits
11/18/2014WainwrightInitiated CoverageBuy$7.00ViewTweet This Rating  Share This Rating on StockTwits
12/23/2013Roth CapitalBoost Price Target$28.00ViewTweet This Rating  Share This Rating on StockTwits
(Data available from 12/18/2012 forward)